1. Home
  2. PAVM vs PDSB Comparison

PAVM vs PDSB Comparison

Compare PAVM & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAVmed Inc.

PAVM

PAVmed Inc.

HOLD

Current Price

$5.11

Market Cap

43.1M

Sector

Health Care

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.76

Market Cap

40.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAVM
PDSB
Founded
2014
2005
Country
United States
United States
Employees
41
10
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.1M
40.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
PAVM
PDSB
Price
$5.11
$0.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$65.00
$9.00
AVG Volume (30 Days)
8.6K
246.2K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$603.94
N/A
Revenue Next Year
$33.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.51
52 Week High
$28.44
$1.55

Technical Indicators

Market Signals
Indicator
PAVM
PDSB
Relative Strength Index (RSI) 44.60 46.85
Support Level $4.45 $0.63
Resistance Level $6.56 $0.76
Average True Range (ATR) 0.46 0.04
MACD -0.01 0.01
Stochastic Oscillator 37.46 76.46

Price Performance

Historical Comparison
PAVM
PDSB

About PAVM PAVmed Inc.

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: